Brief: Zimmer Biomet Receives FDA Clearance For Persona® Revision Solution™ Femur
07/03/2025 13:03
March 7 (Reuters) - Zimmer Biomet Holdings Inc ZBH.N: ZIMMER BIOMET RECEIVES FDA CLEARANCE FOR PERSONA® REVISION SOLUTION™ FEMUR ZIMMER BIOMET HOLDINGS INC - PERSONA REVISION SOLUTION FEMUR AVAILABLE IN U.S. Q3 2025 Source text: ID:nPn11PHCva Further company coverage: ZBH.N (Reuters.Briefs@thomsonreuters.com)
Recent news on Zimmer Biomet Holdings
See all newsMedical device makers slip in sympathy with J&J's MedTech miss
Brief: Zimmer Biomet And THINK Surgical Extend Exclusive Distribution Agreement
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Stryker taps insider Stiles to succeed industry veteran Lobo as CEO